Stay tuned for the 2021 edition!

Presenting Companies

Glycovam conducts Research and Development of Synthetic Peptides, Carbohydrates and Glycoconjugates as Pharmacochemicals and Biopharmaceuticals applicable to Therapeutics and Diagnosis (Theranostics) of conditions affecting animals and humans. In this context is the development of synthetic vaccines and monoclonal antibodies, as well as prototypes for obtaining drugs. Besides, Glycovam provides scientific advice and services related to peptide/glycoconjugate synthesis, immunobiological production, and immunoassay.